Kala Pharmaceuticals Inc. Stock
Kala Pharmaceuticals Inc. took a tumble today and lost -€0.064 (-8.510%).
We see a rather positive sentiment for Kala Pharmaceuticals Inc. with 12 Buy predictions and 1 Sell predictions.
With a target price of 13 € there is potential for a 1789.53% increase which would mean more than doubling the current price of 0.69 € for Kala Pharmaceuticals Inc..
Our community identified positive and negative aspects for Kala Pharmaceuticals Inc. stock for the coming years. 5 users see the criterium "Worthwhile Investment for the next years" as a plus for the Kala Pharmaceuticals Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Kala Pharmaceuticals Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Kala Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kala Pharmaceuticals Inc. | -8.510% | -45.229% | 23.380% | -87.340% | -88.323% | -83.307% | -99.753% |
| Ardelyx Inc. | -1.150% | 4.938% | 4.547% | -6.506% | 1.873% | 194.138% | -2.880% |
| Krystal Biotech | 0.800% | 8.522% | 17.592% | 14.742% | 32.194% | 183.380% | - |
| Evolus Inc | 0.880% | -1.724% | -5.785% | -51.695% | -45.714% | -12.977% | 91.019% |
Comments
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at HC Wainwright from $12.00 to $35.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) had its price target raised by analysts at Oppenheimer Holdings, Inc. from $15.00 to $33.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KALA provided by MarketBeat
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Show more
Ratings data for KALA provided by MarketBeat